InsiderTrades

Form 4 for INSP Inspire Medical Systems, Inc.

Accepted 2023-08-28 00:00:00 ET · period of report 2023-08-23 · accession 0001104659-23-095629 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2023-08-28 2023-08-23 INSP Herbert Timothy P. CEO, Pres, Dir M - OptEx $70.55 +953 107.8K +0.9% +$67.2K
DM 2023-08-28 2023-08-23 INSP Herbert Timothy P. CEO, Pres, Dir M - OptEx $0.00 -953 51.9K -2% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-08-23 M A 938 $71.00 107,769 D — — (F1) Includes 58 additional shares acquired under the Inspire Medical Systems, Inc. 2018 Employee Stock Purchase Plan.
2 Common Common Stock 2023-08-23 M A 15 $42.15 107,784 D — —
3 Derivative Stock Option (Right to Buy) 2023-08-23 M D 938 $0.00 64,062 D $71.00 · — to 2029-12-16 938 Common Stock (F4) The original grant of options to purchase 65,000 shares of common stock vested and became exercisable as to 25% of the underlying shares on the first anniversary of December 16, 2019 and the remaining 75% of the underlying shares have vested or will vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.
4 Derivative Stock Option (Right to Buy) 2023-08-23 M D 15 $0.00 51,913 D $42.15 · — to 2028-12-18 15 Common Stock (F6) A portion of this award is now held by the Timothy P. Herbert 2013 Family Irrevocable GST Trust U/A/D November 27, 2013 and the total held directly by the Reporting Person has been updated accordingly. (F5) The option is fully vested and exercisable.